9Information policy

We maintain a policy of transparent communication with all our stakeholders.

We release our financial results in the form of an annual report. Our annual report is published in electronic form under the links below at the end of this section 9 within four months of the 31 December balance sheet date. In addition, our financial results for the first-half of each fiscal year are released in electronic form under the links below at the end of this section 9 within three months of the 30 June balance sheet date. Our annual report and half-year results are announced via press releases and media and investor conferences held in person, via telephone or video conference / webcast.

In addition, we comply with the requirements of SIX Exchange Regulation on the dissemination of price-sensitive information. Ad hoc announcements can be accessed at the same time as they are communicated to the SIX Exchange Regulation at the links indicated at the end of this section 9. It is further possible to receive material and price-sensitive information directly, promptly and free of charge from PolyPeptide by e-mail. This service is offered under the links indicated at the end of this section 9.

Notices to shareholders and other announcements are made by publication in the Swiss Official Gazette of Commerce. The Board of Directors may designate further means for official publications.

Contact addresses

Copies of all information and documents pertaining to press releases, media conferences, investor updates and presentations at analyst and investor presentation conferences can be downloaded from our website at https://www.polypeptide.com/ or obtained upon request from Investor Relations and Corporate Communications, Dammstrasse 19, 6300 Zug, Switzerland17 (phone: +41 41 723 20 34; email: investorrelations@polypeptide.com).

Main registered office17

PolyPeptide Group AG
Dammstrasse 19
6300 Zug
Switzerland
+41 (0) 41 723 20 40

Weblinks

The Company's website:
https://www.polypeptide.com

Subscription for ad hoc messages (push system):
www.polypeptide.com/news/subscription/

Ad hoc messages (pull system):
www.polypeptide.com/news/

Financial reports:
www.polypeptide.com/investors/results-presentations/

Corporate calendar:
www.polypeptide.com/investors/calendar/

17 At the general meeting on 26 April 2022, shareholders will be asked to approve the change of the Company’s registered office from Zug to Baar, Switzerland, where the Company’s new registered address will be Neuhofstrasse 24, 6340 Baar, Switzerland.

Upcoming Important Dates:

  • 26 April 2022 – General Meeting 2022
  • 27 April 2022 – Last trading day including dividend entitlement
  • 28 April 2022 – Dividend ex-date
  • 29 April 2022 – Dividend record date
  • 2 May 2022 – Dividend payment date
  • 19 August 2022 – Half-year Results 2022
  • 14 March 2023 – Full-year Results 2022
  • 12 April 2023 – General Meeting 2023